Bill Amendment: FL S0630 | 2019 | Regular Session
NOTE: For additional amemendments please see the Bill Drafting List
Bill Title: Nonopioid Alternatives
Status: 2019-04-29 - Laid on Table, companion bill(s) passed, see CS/CS/HB 451 (Ch. 2019-123) [S0630 Detail]
Download: Florida-2019-S0630-Senate_Committee_Amendment_422752.html
Bill Title: Nonopioid Alternatives
Status: 2019-04-29 - Laid on Table, companion bill(s) passed, see CS/CS/HB 451 (Ch. 2019-123) [S0630 Detail]
Download: Florida-2019-S0630-Senate_Committee_Amendment_422752.html
Florida Senate - 2019 COMMITTEE AMENDMENT Bill No. SB 630 Ì422752$Î422752 LEGISLATIVE ACTION Senate . House . . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Health Policy (Perry) recommended the following: 1 Senate Amendment (with title amendment) 2 3 Delete everything after the enacting clause 4 and insert: 5 Section 1. Subsection (7) is added to section 456.44, 6 Florida Statutes, to read: 7 456.44 Controlled substance prescribing.— 8 (7) NONOPIOID ALTERNATIVES.— 9 (a) The Legislature finds that every competent adult has 10 the fundamental right of self-determination regarding decisions 11 pertaining to his or her own health, including the right to 12 refuse an opioid drug listed as a Schedule II controlled 13 substance in s. 893.03 or 21 U.S.C. s. 812. 14 (b) The department shall develop and publish on its website 15 an educational pamphlet regarding the use of nonopioid 16 alternatives for the treatment of pain. The pamphlet must, at a 17 minimum, include: 18 1. Information on available nonopioid alternatives for the 19 treatment of pain, including nonopioid medicinal drugs or drug 20 products and nonpharmacological therapies; and 21 2. The advantages and disadvantages of the use of nonopioid 22 alternatives. 23 (c) Except in the provision of emergency services and care, 24 as defined in s. 395.002, before providing medical treatment or 25 anesthesia or prescribing an opioid drug listed as a Schedule II 26 controlled substance in s. 893.03 or 21 U.S.C. s. 812 for the 27 treatment of pain, a health care practitioner shall: 28 1. Inform the patient of available nonopioid alternatives 29 for the treatment of pain, which may include nonopioid medicinal 30 drugs or drug products, acupuncture, chiropractic treatments, 31 massage therapy, physical therapy, occupational therapy, or any 32 other appropriate therapy as determined by the health care 33 practitioner; 34 2. Discuss the advantages and disadvantages of the use of 35 nonopioid alternatives, including whether the patient is at a 36 high risk of, or has a history of, controlled substance abuse or 37 misuse and the patient’s personal preferences; 38 3. Provide the patient with the educational pamphlet 39 described in paragraph (b); and 40 4. Document the nonopioid alternatives considered in the 41 patient’s record. 42 Section 2. This act shall take effect July 1, 2019. 43 44 ================= T I T L E A M E N D M E N T ================ 45 And the title is amended as follows: 46 Delete everything before the enacting clause 47 and insert: 48 A bill to be entitled 49 An act relating to nonopioid alternatives; amending s. 50 456.44, F.S.; providing a legislative finding; 51 requiring the Department of Health to develop and 52 publish on its website an educational pamphlet 53 regarding the use of nonopioid alternatives for the 54 treatment of pain; requiring that the pamphlet include 55 specified information, including the advantages and 56 disadvantages of the use of such alternatives; 57 providing requirements for health care practitioners; 58 providing an exception; providing an effective date.